Allstate (ALL) Misses Q4 EPS by 34c, Revenue Beats
Tweet
Share
E-mail
Get Alerts ALL Hot Sheet
Price: $255.84 --0%
Financial Fact:
Income tax (benefit) expense: 245M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Income tax (benefit) expense: 245M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Allstate (NYSE: ALL) reported Q4 EPS of ($1.36), $0.34 worse than the analyst estimate of ($1.02). Revenue for the quarter came in at $13.65 billion versus the consensus estimate of $11.32 billion.
For earnings history and earnings-related data on Allstate (ALL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi downgrades Allstate to Sell with $240 price target
- CorMedix (CRMD) Tops Q2 EPS by 6c; Offers Guidance
- Bending Spoons S.p.A. (BSP) Tops Q2 EPS by 19c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
